These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17900217)

  • 1. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
    Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
    Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
    Kedes DH; Lagunoff M; Renne R; Ganem D
    J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay.
    Olsen SJ; Sarid R; Chang Y; Moore PS
    J Infect Dis; 2000 Jul; 182(1):306-10. PubMed ID: 10882613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.
    Burnside KL; Ryan JT; Bielefeldt-Ohmann H; Gregory Bruce A; Thouless ME; Tsai CC; Rose TM
    Virology; 2006 Oct; 354(1):103-15. PubMed ID: 16879850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
    Cotter MA; Subramanian C; Robertson ES
    Virology; 2001 Dec; 291(2):241-59. PubMed ID: 11878894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.
    Mbisa GL; Miley W; Gamache CJ; Gillette WK; Esposito D; Hopkins R; Busch MP; Schreiber GB; Little RF; Yarchoan R; Ortiz-Conde BA; Labò N; Whitby D
    J Immunol Methods; 2010 Apr; 356(1-2):39-46. PubMed ID: 20211626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
    Ohsaki E; Suzuki T; Karayama M; Ueda K
    Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
    Cotter MA; Robertson ES
    Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
    Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
    FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus.
    Zaldumbide A; Ossevoort M; Wiertz EJ; Hoeben RC
    Mol Immunol; 2007 Feb; 44(6):1352-60. PubMed ID: 16828498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 inhibition by the LANA protein of KSHV protects against cell death.
    Friborg J; Kong W; Hottiger MO; Nabel GJ
    Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis.
    Nascimento MC; de Souza VA; Sumita LM; Freire W; Munoz F; Kim J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Mar; 45(3):715-20. PubMed ID: 17182752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.
    Kellam P; Boshoff C; Whitby D; Matthews S; Weiss RA; Talbot SJ
    J Hum Virol; 1997; 1(1):19-29. PubMed ID: 10195227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
    Ohsaki E; Ueda K; Sakakibara S; Do E; Yada K; Yamanishi K
    J Virol; 2004 Sep; 78(18):9936-46. PubMed ID: 15331727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.
    Kelley-Clarke B; Ballestas ME; Komatsu T; Kaye KM
    Virology; 2007 Jan; 357(2):149-57. PubMed ID: 16979209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
    Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
    PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.